ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 85 filers reported holding ATRECA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6 | -73.9% | 23 | 0.0% | 0.00% | – |
| Q2 2023 | $23 | – | 23 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 23 | -99.8% | 0.00% | – |
| Q1 2022 | $39,000 | -93.8% | 12,205 | -94.1% | 0.00% | – |
| Q4 2021 | $629,000 | -36.8% | 207,635 | +30.0% | 0.00% | – |
| Q3 2021 | $995,000 | +58.7% | 159,733 | +117.3% | 0.00% | – |
| Q2 2021 | $627,000 | +145.9% | 73,493 | +344.3% | 0.00% | – |
| Q1 2021 | $255,000 | +23.2% | 16,542 | +29.2% | 0.00% | – |
| Q4 2020 | $207,000 | +38.9% | 12,808 | +22.0% | 0.00% | – |
| Q3 2020 | $149,000 | -2.0% | 10,496 | +46.3% | 0.00% | – |
| Q2 2020 | $152,000 | +65.2% | 7,176 | +29.1% | 0.00% | – |
| Q1 2020 | $92,000 | +178.8% | 5,558 | +160.1% | 0.00% | – |
| Q4 2019 | $33,000 | +26.9% | 2,137 | +0.1% | 0.00% | – |
| Q3 2019 | $26,000 | – | 2,134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,320,880 | $2,100,000 | 1.66% |
| CM Management, LLC | 249,282 | $391,000 | 0.44% |
| Aisling Capital Management LP | 387,653 | $609,000 | 0.40% |
| Boxer Capital, LLC | 2,202,333 | $3,458,000 | 0.19% |
| Samsara BioCapital, LLC | 396,835 | $623,000 | 0.14% |
| Redmile Group, LLC | 800,306 | $1,256,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 191,442 | $301,000 | 0.04% |
| Baker Brothers Advisors | 3,532,760 | $5,546,000 | 0.04% |
| Cormorant Asset Management, LP | 319,057 | $501,000 | 0.04% |
| Rock Springs Capital Management LP | 462,530 | $726,000 | 0.02% |